Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118812352 | 11881235 | 2 | F | 20140220 | 20160701 | 20151231 | 20160805 | PER | US-009507513-1512USA007300 | MERCK | 29.00 | YR | F | Y | 0.00000 | 20160805 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118812352 | 11881235 | 1 | SS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | 1 DF, QD (ALSO REPORTED AS 600 UNITS NOT REPORTED) | U | U | 0 | 1 | DF | TABLET | QD | ||||
| 118812352 | 11881235 | 2 | PS | RALTEGRAVIR POTASSIUM | RALTEGRAVIR POTASSIUM | 1 | Oral | 1 DF, QD(ALSO REPORTED AS 800 UNITS NOT REPORTED) | U | U | 22145 | 1 | DF | TABLET | QD | ||||
| 118812352 | 11881235 | 3 | SS | emtricitabine (+) tenofovir disoproxil fumarate | EMTRICITABINETENOFOVIR DISOPROXIL | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 118812352 | 11881235 | 4 | SS | emtricitabine (+) tenofovir disoproxil fumarate | EMTRICITABINETENOFOVIR DISOPROXIL | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 118812352 | 11881235 | 5 | SS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Oral | 1 DF, QD(ALSO REPORTED AS 400 UNITS NOT REPORTED) | U | 0 | 1 | DF | QD | ||||||
| 118812352 | 11881235 | 6 | SS | RITONAVIR. | RITONAVIR | 1 | Oral | 1 DF, QD(ALSO REPORTED AS 100 (UNITS NOT PROVIDED)) | U | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118812352 | 11881235 | 1 | Antiretroviral therapy |
| 118812352 | 11881235 | 2 | Antiretroviral therapy |
| 118812352 | 11881235 | 3 | Antiretroviral therapy |
| 118812352 | 11881235 | 5 | Antiretroviral therapy |
| 118812352 | 11881235 | 6 | Antiretroviral therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118812352 | 11881235 | Maternal exposure during pregnancy | |
| 118812352 | 11881235 | No adverse event | |
| 118812352 | 11881235 | Normal newborn | |
| 118812352 | 11881235 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |